W
Wedbush Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
76 |
76
IMAX
IMAX
$1.57B
|
AR
Alicia Reese
| $29.21 | $35 |
20%
upside
| Outperform | 1 month ago |
|
77 |
77
Pegasystems
PEGA
$9.21B
|
DI
Daniel Ives
| $53.81 | $70 |
30%
upside
| Outperform | 1 month ago |
|
78 |
78
D.R. Horton
DHI
$52.7B
|
JM
Jay McCanless
| $176.69 | $170 |
4%
downside
| Neutral | 1 month ago |
|
79 |
79
Replimune Group
REPL
$454M
|
RD
Robert Driscoll
| $5.81 | $4 |
31%
downside
| Neutral | 1 month ago |
|
80 |
80
Marcus Corp
MCS
$479M
|
AR
Alicia Reese
| $15.29 | $24 |
57%
upside
| Outperform | 1 month ago |
|
81 |
81
Unity
U
$17B
|
MP
Michael Pachter
| $40.18 | $39 |
3%
downside
| Outperform | 1 month ago |
|
82 |
82
Netflix
NFLX
$534B
|
MP
Michael Pachter
| $1,257.48 | $1,400 |
11%
upside
| Outperform | 1 month ago |
|
83 |
83
Ultragenyx Pharmaceutical
RARE
$3.01B
|
LC
Laura Chico
| $31.28 | $34 |
9%
upside
| Neutral | 1 month ago |
|
84 |
84
Cinemark Holdings
CNK
$2.92B
|
AR
Alicia Reese
| $25.41 | $37 |
46%
upside
| Outperform | 1 month ago |
|
85 |
85
AMC Entertainment Holdings
AMC
$1.4B
|
MP
Michael Pachter
| $2.72 | $4 |
47%
upside
| Outperform | 1 month ago |
|
86 |
86
Cartesian Therapeutics
RNAC
$260M
|
MF
Martin Fan
| $10 | $38 |
280%
upside
| Outperform | 1 month ago |
|
87 |
MAZE
87
Maze Therapeutics, Inc. Common Stock
MAZE
$660M
|
LC
Laura Chico
| $15.04 | $17 |
13%
upside
| Outperform | 1 month ago |
|
88 |
88
Progress Software
PRGS
$1.9B
|
DI
Daniel Ives
| $44.18 | $75 |
70%
upside
| Outperform | 2 months ago |
|
89 |
89
BioCryst Pharmaceuticals
BCRX
$1.74B
|
LC
Laura Chico
| $8.27 | $18 |
118%
upside
| Outperform | 2 months ago |
|
90 |
90
Micron Technology
MU
$139B
|
MB
Matt Bryson
| $124.21 | $165 |
33%
upside
| Outperform | 2 months ago |
|
91 |
91
TMC The Metals Company
TMC
$2.08B
|
DI
Daniel Ives
| $5.12 | $11 |
115%
upside
| Outperform | 2 months ago |
|
92 |
92
argenx
ARGX
$44.9B
|
DN
David Nierengarten
| $733.66 | $715 |
3%
downside
| Outperform | 2 months ago |
|
93 |
93
Larimar Therapeutics
LRMR
$331M
|
LC
Laura Chico
| $3.87 | $15 |
288%
upside
| Outperform | 2 months ago |
|
94 |
94
Perspective Therapeutics
CATX
$263M
|
DN
David Nierengarten
| $3.54 | $11 |
211%
upside
| Outperform | 2 months ago |
|
95 |
95
Wave Life Sciences
WVE
$1.3B
|
YZ
Yun Zhong
| $8.18 | $18 |
120%
upside
| Outperform | 2 months ago |
|
96 |
96
The GEO Group
GEO
$2.99B
|
JM
Jay McCanless
| $21.14 | $36 |
70%
upside
| Outperform | 2 months ago |
|
97 |
97
Nice
NICE
$8.56B
|
DI
Daniel Ives
| $138.67 | $200 |
44%
upside
| Outperform | 2 months ago |
|
98 |
98
Kura Oncology
KURA
$706M
|
RD
Robert Driscoll
| $8.13 | $36 |
343%
upside
| Outperform | 2 months ago |
|
99 |
99
Builders FirstSource
BLDR
$15.8B
|
JM
Jay McCanless
| $143.27 | $145 |
1%
upside
| Outperform | 2 months ago |
|
100 |
100
IBM
IBM
$230B
|
DI
Daniel Ives
| $247.18 | $325 |
31%
upside
| Outperform | 2 months ago |
|